Cover Image
QR Code

Linfadenectomía retroperitoneal en el manejo del cáncer testicular germinal no seminomatoso, etapa clínica I.

Introduction: Testicular cancer represents 1% of all the malignant tumors, being commonest between 15 and 34 years of age. The incidence has been increased of 3.26 to 5.44/100.000 cases, from 1973 to the date. The multimodal therapy of nonseminomatous testicular cancer in clinical stage 1 (CS1) incl...

Full description

Published in:Boletín del Colegio Mexicano de Urología Vol. 22; no. 1; pp. 33 - 39
Main Authors: Neri-Páez, E., Huerta-Gómez, J. C., Hernández-Toriz, N., Ramírez-Reyes, A. G.
Format: Article
Published: Colegio Mexicano de Urologia A.C. ene-abr2007
Subjects:
Testicular cancer
Cancer treatment
Retroperitoneum
Metastasis
Cancer chemotherapy
Patient monitoring
Online Access:View this record in EBSCOhost